ReWalk Robotics Ltd. (NASDAQ:LFWD) Sees Significant Decrease in Short Interest

ReWalk Robotics Ltd. (NASDAQ:LFWD) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 760,400 shares, a decline of 69.7% from the March 15th total of 2,510,000 shares. Currently, 8.1% of the company’s stock are short sold. Based on an average daily volume of 2,460,000 shares, the days-to-cover ratio is currently 0.3 days.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Lake Street Capital decreased their target price on ReWalk Robotics from $4.50 to $4.00 and set a “buy” rating for the company in a research report on Tuesday, March 11th. Laidlaw began coverage on ReWalk Robotics in a research report on Monday, February 10th. They set a “buy” rating and a $10.00 price objective for the company. Finally, HC Wainwright reiterated a “buy” rating and issued a $13.00 target price on shares of ReWalk Robotics in a report on Tuesday, March 11th.

ReWalk Robotics Stock Down 2.1 %

Shares of NASDAQ:LFWD traded down $0.03 during trading on Wednesday, reaching $1.39. 45,582 shares of the company traded hands, compared to its average volume of 670,660. The firm has a fifty day simple moving average of $1.67 and a 200 day simple moving average of $1.93. ReWalk Robotics has a 1-year low of $1.22 and a 1-year high of $5.28. The firm has a market cap of $14.78 million, a P/E ratio of -0.56 and a beta of 1.51.

ReWalk Robotics (NASDAQ:LFWD) last released its quarterly earnings data on Friday, March 7th. The company reported ($1.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.53). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The firm had revenue of $7.55 million for the quarter, compared to analyst estimates of $7.30 million. As a group, research analysts anticipate that ReWalk Robotics will post -1.78 EPS for the current year.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.